Search

Displaying results 6841 - 6850 of 10000 in total
  1. Drug

    Premazepam

    go.drugbank.com/drugs/DB21027
    Experimental

    Premazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Premazepam is a diazepam derivative. Premazepam has a monoisotopic molecular weight of 253.12 Da.

  2. Drug

    Elfazepam

    go.drugbank.com/drugs/DB21142
    Experimental

    Elfazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Elfazepam is a diazepam derivative. Elfazepam has a monoisotopic molecular weight of 408.07 Da.

  3. Drug

    Maroxepin

    go.drugbank.com/drugs/DB21379
    Experimental

    Maroxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Maroxepin is a tricyclic compound. Maroxepin has a monoisotopic molecular weight of 277.15 Da.

  4. Drug

    Reclazepam

    go.drugbank.com/drugs/DB21411
    Experimental

    Reclazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Reclazepam is a diazepam derivative. Reclazepam has a monoisotopic molecular weight of 373.04 Da.

  5. Drug

    Metoxepin

    go.drugbank.com/drugs/DB21433
    Experimental

    Metoxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Metoxepin is a tricyclic compound. Metoxepin has a monoisotopic molecular weight of 322.17 Da.

  6. Drug

    Rizedisben

    go.drugbank.com/drugs/DB21610
    Investigational

    Rizedisben is a small molecule drug. Rizedisben is under investigation in clinical trial NCT04983862 (Fluorescent Imaging of Nerves with Illuminare-1 During Surgery). … Rizedisben has a monoisotopic molecular weight of 519.22 Da.

  7. Drug

    Davelizomib

    go.drugbank.com/drugs/DB21660
    Experimental

    Davelizomib is a small molecule drug. The usage of the INN stem '-zomib' in the name indicates that Davelizomib is a proteasome inhibitor. Davelizomib has a monoisotopic molecular weight of 481.18 Da.

  8. Drug

    NasoVAX

    go.drugbank.com/drugs/DB15859
    Investigational

    NasoVAX contains replication-deficient adenovirus vectors in suspension. It is a vaccine administered through a nasal spray that expresses influenza hemagglutinin in nasal epithelial cells[L16313]. … As of June 2020, NasoVAX is being evaluated in a Phase 2 clinical trial for safety and effectivness in preventing worsening symptoms in hospitalized COVID-19 patients (NCT04442230).

  9. Drug

    SGS518

    go.drugbank.com/drugs/DB05042
    Experimental

    SGS518, a novel antagonist for the 5HT6 subtype of the serotonin receptor, is being developed as a treatment for Cognitive Impairment Associated with Schizophrenia (CIAS).

  10. Drug

    Ledaborbactam etzadroxil

    go.drugbank.com/drugs/DB21455
    Investigational

    Ledaborbactam etzadroxil is a small molecule drug. The usage of the INN stem '-bactam' in the name indicates that Ledaborbactam etzadroxil is a ẞ-lactamase inhibitor. … Ledaborbactam etzadroxil has a monoisotopic molecular weight of 391.18 Da.